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ABSTRACT
Diabetes is considered a risk factor for arteriovenous fistula failure and increased perioperative complications; but this view is
not proven for patients undergoing brachiobasilic transposition arteriovenous fistula (BBT-AVF). Fifty-one (68.9%) diabetic and
23 (31.08%) non-diabetic patients undergoing single-stage BBT-AVF were compared in terms of perioperative complications,
access maturation and patency rates at The Aga Khan University Hospital from between January 2016 to December 2017.
Diabetics were elder and more obese. The perioperative complications 19 (37.2%) vs. 8 (34.7%), and access maturation rates
were compared (93.2% vs. 95.5%) between the two groups. At 6 months, access patency in diabetics was lower compared to
non-diabetics (64.7% vs. 87.0%).  Similar trend was noted at 12 and 24 months in both groups.
This study showed that the diabetic and non-diabetic were comparable in terms of perioperative complications and maturation
rate. However, short term patency rate was lower in diabetics compared to non-diabetics.
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In literature, there is wide variations of primary patency for
brachiobasilic transposition arteriovenous fistula (BBT-AVF).
Same is true for the perioperative complications. This wide
variability may be due to heterogeneous patient population in
the published studies, including both diabetic and non-dia-
betic patients. Patients with long standing diabetes develop
medial calcification in their arteries, which prevents its dilata-
tion and increase flow within the fistula.1 Distal brachial artery
along  with  forearm  arteries  may  be  involved  in  extensive
atherosclerosis, which is inflow site for most of elbow AVFs.
This can be associated with delayed AVF maturation or its
early failure.
Diabetes is also a negative predictor of venous remodelling.2
Endothelial dysfunction in diabetics causes less nitric oxide
production,  increased platelet  aggregation and pro-coagu-
lant  state,  which can delay maturation or  poor patency of
AVF.3 Diabetics are immune-compromised and more prone to
surgical site infection.1 
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Based on these factors, the authors hypothesised that patency of
AVF may be lower and the incidence of complications may be
higher in diabetic compared to non-diabetic patients undergoing
BBT-AVF. There is enough data to support these impressions for
forearm fistulas; but limited evidence for the BBT-AVF.
The objective of the study was to compare the perioperative
complications, access maturation, and patency rate in diabetic
and non-diabetic patients’ undergoing BBT-AVF.
This observational study was conducted at The Aga Khan Univer-
sity Hospital, Karachi (Pakistan) from January 2016 to December
2017; and included all adult patients who had undergone single-s-
tage BBT-AVF. The cohort was followed for at least one year.
Patients undergone two-stage BBT-AVFs were excluded from the
study.
After obtaining exemption from the Institutional Ethical Review
Board  (2018-0663-727),  medical  records  of  the  patients,  who
underwent BBT-AVF, were retrieved from the electronic database
using ICD coding. Data of patients’ age, gender, body mass index,
primary  renal  pathology  leading  to  end-stage  renal  disease,
comorbidities, previous vascular access if any, preoperative size
of basilic vein, anesthesia used for surgery, total operative time,
early or late complications, time for first needle puncture, primary
patency,  first  re-intervention  time,  total  interval  between  the
initial procedure and until the fistula is lost and causes of fistula
failure, were recorded. The complications include arm oedema,
wound  infection,  graft  thrombosis,  stenosis,  steal  syndrome,
haematoma / bleeding and re-interventions.
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Table I: Patient’s characteristics and outcomes.
Variable Diabetic (n=51) Non-diabetic (n=23) p-value
Age (years) 60.27 ± 8.96 43.78 ± 17.41 <0.001   
BMI (kg/m2) 28.32 ± 7.18 23.59 ± 4.51 0.005
Female gender 39 (76.47%) 10 (43.48%) 0.005
HTN 49 (96.08%) 19 (82.61%) 0.071
IHD 21 (41.18%) 4 (17.39%) 0.063
CVA 5 (9.80%) 3 (13.04%) 0.698
Hypothyroidism 4 (7.84%) 2 (8.70%) 0.999
Hemodialysis 30 (58.82%) 13 (56.52%) 0.853
Previous hemodialysis access 26 (50.98%) 11 (47.83%) 0.802
Duration of hemodialysis (years) Median: 0.25 (0-8) Median: 0.5 (0-20) 0.288














Operative time (minutes) 141.13 ± 30.55 145.55 ± 37.25 0.604























First needle prick time (weeks) 6.44 ± 2.38 8.19 ± 10.10 0.303






























BMI = Body mass index; HTN= Hypertension; IHD= Ischemic heart disease; CVA= Cerebrovascular accident;  *Loss to follow-up excluded.
Fistula  was  considered  ‘matured,’  if  it  has  satisfactory  flow
and palpable vein after 6-8 weeks, as defined by rule of 6s in
KDOQI guidelines. Primary patency was time-duration from
fistula  creation  to  first  intervention.  Secondary/cumulative
patency  was  the  total  duration  fistula-remained  patent,
despite  having  multiple  interventions.
Data were entered and analysed using SPSS version 22.
Quantitative variables were reported as mean ± SD and/or
medians (range) and categorical variables were presented
with  frequencies  and  percentages.  Group  differences  were
assessed by Independent t test/Mann-Whitney test or Chi-
square/Fisher exact test. A p-value <0.05 was considered
significant.
During the study duration, 74 patients had BTT-AVF, out of
them 51 (68.9%) were diabetic, while 23 (31.08%) were non-di-
abetic patients. There was more proportion of female patients
in diabetics (76.47% vs.  43.48%).  Mean age (years)  of  the
diabetic  patients  were  higher  compared  to  non-diabetics
(60.27  ±8.9  vs.  43.78  ±17.41,  p  <0.00).  BMI  of  diabetic
patients was also higher compared to non-diabetics ((28.32 ±
7.18 vs. 23.59 ± 4.51, p = 0.005). Other demographics and
preoperative  and  intraoperative  variables  were  comparable
(Table I). No significant difference in overall complication rates
between the two groups were noted (p  = 0.838,  Table  I).
Although, diabetic patients experienced a trend towards more
steal syndromes (19.6% vs. 13.04%, p=0.743).  
Seven  diabetic  and  one  non-diabetic  patient  was  lost  to
follow-up at 8 weeks; hence, 44 diabetic and 22 non-diabetic
patients  were  available  and  assessed  for  fistula  maturation
and  patency.  Access  maturation  rates  were  comparable
(93.2% vs. 95.5%) between the two groups. At 6 months, a
trend of lower patency rate was noted in diabetics (64.7%
vs. 87.0%).  The patency rates at 12 and 24 months were
63.6% vs. 70.0% and 27.3% vs. 14.3%, respectively.
Diabetic nephropathy is the most common cause of renal
failure;  and  usually  affects  elder  population.  Most  of  the
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other  conditions  of  renal  failure  affect  the  younger  popula-
tion.  There  are  limited  studies  addressing  the  effects  of
diabetes on the outcomes of the BBT-AVF, specifically. Most
of the studies focused increased AVF failure rate in diabetic
patients undergoing radiocephalic AVFs.4 The present results
are consistent with recently published studies, Fontseré et
al. noted diabetics had worse patency rates than non-dia-
betic patients.5
The present results differ from other studies. Zouaghi et al.
evaluated  126  AVFs  for  its  patency  and  its  determinant
factors, 39.6% were diabetics in that cohort, only 18 (14.3%)
had BBT-AVF; diabetes did not come as a risk factor for poor
patency.6
Higher frequency of steal syndrome in diabetics may also be
due more elderly (having advance atherosclerosis) and female
(having  smaller  vessel  diameter)  patients  in  this  cohort.
Limited patency in diabetics can be due to advance atheroscle-
rosis and poor vessel remodeling, which is expected in these
patients.  Preoperative  ultrasound  was  performed  in  most
patients, but complete data for arterial assessment was not
available. This was one of the limitations of this retrospective
study, others being from a single-centre with limited number
of  patients.  A  prospective,  multi-centre  study  with  larger
sample size can better improve these results.
This study showed that the diabetic and non-diabetic patients
undergoing BBT-AVF were comparable in terms of periopera-
tive  complications  and maturation  rate.  However,  diabetics
had more incidences of steal syndrome compared to non-dia-
betic patients. Short term patency rate was lower in diabetics
compared to non-diabetics.
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